IP Library Granted Patent US 7,355,025
Granted Patent B2
US 7,355,025 · App. 10/515,477 · Granted Apr 8, 2008

Marker molecules associated with lung tumors

Assignee: MTM Laboratories, AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,355,025
App. No.
10/515,477
Granted
Apr 8, 2008
Kind
B2
Abstract

The present invention relates to nucleic acids and polypeptides associated with lung cancer. The invention is more specifically related to a nucleic acids and the polypeptides transcribed thereof, the expression of which is significantly altered in association with lung cancer. The invention relates to a series of differentially spliced transcripts of the gene disclosed herein, that are associated with tumors of the respiratory tract. Furthermore the present invention provides a method for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as e.g. lung tumors.

Claims (12)

1. An isolated nucleic acid comprising: (a) SEQ ID NO: 1, 3, or 5, or (b) a nucleic acid molecule having a sequence different from the sequence of the cDNA or mRNA of SEQ ID NO: 1, 3, or 5 due to the degeneracy of the genetic code of the cDNA or mRNA, wherein said nucleic acid molecule encodes the amino acid sequence of SEQ ID NO: 2, 4, or 6, respectively.

2. An isolated recombinant vector comprising the nucleic acid molecule of claim 1 .

3. The isolated recombinant vector of claim 2 wherein the nucleic acid molecule is operatively linked to regulatory elements allowing transcription and synthesis of a translatable RNA in prokaryotic and/or eukaryotic host cells.

4. An isolated recombinant host cell which contains the recombinant vector of claim 2 .

5. The recombinant host cell of claim 4 , which is a mammalian cell, a bacterial cell, an insect cell or a yeast cell.

6. An isolated chimeric nucleic acid comprising the isolated nucleic acid according to claim 1 .

7. An isolated DNA or RNA that is the full complement of the isolated nucleic acid of claim 1 .

8. The isolated nucleic acid according to claim 1 , which is detectably labeled.

9. The isolated nucleic acid according to claim 8 , wherein the label is selected from the group consisting of a radioisotope, a bioluminescent compound, a chemiluminescent compound, a fluorescent compound, a metal chelate, biotin, digoxygenin and an enzyme.

10. The isolated nucleic acid according to claim 1 , which comprises SEQ ID NO: 1.

11. The isolated nucleic acid according to claim 1 , which comprises SEQ ID NO: 3.

12. The isolated nucleic acid according to claim 1 , which comprises SEQ ID NO: 5.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2014
From: ROCHE MTM LABORATORIES AG
To: VENTANA MEDICAL SYSTEMS, INC.
Reel/Frame 032630/0218 →
CHANGE OF NAME Recorded Nov 15, 2011
From: MTM LABORATORIES AG
To: ROCHE MTM LABORATORIES AG
Reel/Frame 027232/0381 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED ON REEL 015517 FRAME 0951. ASSIGNOR(S) HEREBY CONFIRMS THE MTM LABORATORIES, AG IM NEUENHEIMER FELD 583 69120 HEIDELBERG, GERMANY. Recorded Jan 12, 2005
From: COY, JOHANNES; HIPFEL, RAINER; WASSER, BIRGIT
To: MTM LABORATORIES, AG
Reel/Frame 015555/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2005
From: COY, JOHANNES; HIPFEL, RAINER; WASSER, BIRGIT
To: SIPIX IMAGING, INC.
Reel/Frame 015517/0951 →
Priority Claims (1)
EP 02010275 · May 21, 2002 · regional
Continuity (1)
Related Publication 20050176930A1 · Aug 11, 2005